DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Orfadin (Nitisinone) - Epilepsy - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Epilepsy (4)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Orfadin (Nitisinone) where reactions include epilepsy. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Orfadin side effects in 12 year old male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-02-08

Patient: 12 year old male

Reactions: Drug Ineffective, Amino Acid Level Decreased, Amino Acid Level Increased, Cognitive Disorder, Epilepsy

Drug(s) suspected as cause:
Orfadin



Possible Orfadin side effects in 12 year old male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2011-12-15

Patient: 12 year old male

Reactions: Amino Acid Level Increased, Cognitive Disorder, Epilepsy

Drug(s) suspected as cause:
Orfadin



Possible Orfadin side effects in female

Reported by a individual with unspecified qualification from France on 2011-11-16

Patient: female, weighing 94.0 kg (206.8 pounds)

Reactions: Maternal Exposure During Pregnancy, Epilepsy, Treatment Noncompliance, Social Problem, Educational Problem, Therapy Cessation, Eclampsia, Posterior Reversible Encephalopathy Syndrome, Obesity, Inappropriate Antidiuretic Hormone Secretion, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Orfadin



Possible Orfadin side effects in female

Reported by a individual with unspecified qualification from Sweden on 2011-11-01

Patient: female

Reactions: Eclampsia, Obesity, Death of Relative, Epilepsy, Hypertension, Treatment Noncompliance

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Orfadin

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017